Generated: May 23, 2017
|Title:||Use of inhibitors of the renin-angiotensin system|
|Abstract:||It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.|
|Inventor(s):||Montgomery; Hugh Edward (London, GB), Martin; John Francis (London, GB), Erusalimsky; Jorge Daniel (London, GB)|
|Assignee:||FinVector Vision Therapies, Ltd. (Oxfordshire, GB)|
|Filing Date:||Jan 30, 2012|
|Claims:||1. A method for the treatment of a person, wherein said method comprises administering to a person with hypertension and left ventricular hypertrophy in need of such treatment an inhibitor of the renin-angiotensin system wherein the inhibitor is an AT.sub.I receptor antagonist and wherein said antagonist consists of losartan in an amount effective to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.